News From the American Society of Hematology (ASH) 2018 Annual Meeting

Patient Power was on-site at the 2018 American Society of Hematology (ASH) meeting in San Diego, Calif, to bring you the latest blood cancer-related treatment and research news.

AML

When Should AML Patients Consider a Transplant?

When is the right time to think about whether a transplant is right for an AML patient? Watch now to hear AML experts explain discussion to have with your doctor.

Published:

AML Treatment Developments: Key Takeaways From ASH 2018

In 2018, there were more changes in AML treatment than in the last 40 years. Watch as Dr. Naval Daver explains some of the research and treatment news from ASH 2018 and beyond.

Published:

Clinical Trial Participation: Propelling Advances in AML Treatment

Can you help in the advancement in the treatment of AML? Experts speak on the importance of clinical trials and how they can improve advancement of AML treatments for all patients.

Published:

Newly Diagnosed With AML? What Patients Need to Know

Where should patients and families turn when newly diagnosed with AML? What questions should they be asking? Watch as leading AML experts give insight.

Published:

Understanding Driver Mutations in AML: What Is Next-Generation Sequencing?

How can we better understand AML? Watch AML experts as they break down how genetic testing helps determine the best treatments by AML disease type.

Published:

ASH 2018 AML Treatment and Research Updates From an Expert Roundtable

Patient Power founders Andrew and Esther Schorr are joined by a panel of AML experts to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting in what they call an “AML treatment revolution.” Tune in to find out the latest news.

Published:

CLL

Achieving CLL Treatment Goals: Why Is MRD-Negative Status Important?

What is the significance of MRD-negative status for CLL patients? Tune in to hear CLL expert and patient perspectives on individualized treatment goals, assessing treatment response and the MRD testing value.

Published:

Tests to Get Before Receiving CLL Personalized Medicine

How sophisticated should testing be before starting CLL treatment? Watch now as Javier Pinilla-Ibarz discusses testing for CLL, when it is recommended and how the results are used.

Published:

Therapies in the Pipeline for CLL

CLL experts Dr. Nicole Lamanna and Dr. Jeff Sharman share exciting research updates on second-generation CLL therapies and discuss treatment sequencing to optimize patient care. Watch now to find out more.

Published:

CLL Research Developments on CAR T-Cell Therapy

Which types of cancers can be treated with CAR T-cell therapy? Watch now as CLL experts share the latest developments in treatment research for the landmark immunotherapy.

Published:

Clinical Trial Updates on CLL Patients With Genetic Mutations

What implications does mutational status have for frontline treatment of CLL? Watch as CLL expert Dr. Jeff Sharman discusses recent studies on the correct management of frontline CLL treatment.

Published:

Novel Agents for CLL: What Does the Side Effect Profile Look Like?

Will side effects from novel agents be less severe? CLL experts Dr. Nitin Jain and Dr. Javier Pinilla-Ibarz discuss potential complications and symptoms from second-generation CLL treatments.

Published:

Clinical Data Update: The Transitioning Role of Chemoimmunotherapy in CLL Care

Is chemotherapy being cut from the frontline? Tune in to our ASH 2018 coverage to hear CLL experts Dr. Nicole Lamanna and Dr. Jeff Sharman explain updates on frontline and re-treatment research and how mutations influence treatment.

Published:

ASH CLL News 2018: Tools for Staying Up-to-Date on Research

At the recent 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson interviews Dr. Anthony Mato to review key research developments.

Published:

CLL Access to Care: How Patients Can Get Access to the Latest Treatments

How can CLL patients access the latest treatments? Watch as experts Dr. Gwen Nichols, Dr. Larry Saltzman, Dr. Kathleen Toomy and Hildy Dillon share insights.

Published:

Showing 9 of 14 programs

CML

An Expert Review of ASH 2018 CML News

At the 2018 American Society of Hematology (ASH) conference in San Diego, Patient Power host and CLL patient advocate, Lee Swanson, is joined by Dr. Michael Mauro, from Memorial Sloan Kettering Cancer Center.

Published:

CML News at ASH 2018: Data From Treatment-Free Remission Studies

What's the latest news in CML treatment-free remission studies at ASH 2018? Watch as CML expert Dr. Michael Savona shares encouraging CML treatment and research developments.

Published:

CML News From ASH: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Jan Geissler, a patient advocate and director of the European Patients Academy on Therapeutic Innovation, joined Patient Power to share his perspective on the latest news in chronic myeloid leukemia (CML).

Published:

Follicular Lymphoma

Follicular Lymphoma Updates From ASH 2018

Dr. Neel Gupta speaks with Andrew Schorr about new and improving therapies for follicular lymphoma from ASH 2018.

Published:

Follicular Lymphoma News at ASH 2018: An Update From Dr. Peter Martin

From the 2018 American Society of Hematology (ASH) annual meeting in San Diego, Patient Power founder Andrew Schorr is joined by leading expert Dr. Peter Martin to discuss follicular lymphoma treatment news announced at the conference. Watch now to stay up-to-date with the latest research.

Published:

Hodgkin Lymphoma

Access to Effective Hodgkin Lymphoma Care at the Community Level

Are innovative Hodgkin lymphoma treatments offered at the community level? Why is it important for patients to consult with a specialist? Watch as experts discuss collaboration with community oncologists.

Published:

How Are Young Adults With Hodgkin Lymphoma Impacted by Treatment?

When can young adults with Hodgkin lymphoma return to work or school after treatment? Watch as Dr. Joshua Brody and Dr. Andrew Evens discuss the duration of therapy, side effects and recovery.

Published:

What Should Hodgkin Lymphoma Patients Know About Survivorship?

What does a survivorship care plan look like for Hodgkin lymphoma patients? Watch as Dr. Joshua Brody and Dr. Andrew Evens share long-term considerations for survivors, post-treatment risk factors and more.

Published:

An Expert Addresses Fertility Concerns for Hodgkin Lymphoma Patients

How does Hodgkin lymphoma treatment affect fertility? Tune in as Dr. Andrew Evens and Dr. Joshua Brody offer expert perspectives on first- and second-line treatment approaches and the effects on fertility.

Published:

What Role Does Genetic Testing Play in Hodgkin Lymphoma Care?

Is it important for Hodgkin lymphoma patients to undergo genetic testing at diagnosis? Watch as Dr. Joshua Brody and Dr. Andrew Evens discuss genomic changes that may occur and how they change the course of care.

Published:

Will Hodgkin Lymphoma Patients Benefit From Checkpoint Inhibitors?

Do checkpoint inhibitors have a role in Hodgkin lymphoma care as a frontline treatment? Watach as Dr. Andrew Evens and Dr. Joshua Brody discuss the latest research developments, immunotherapy and more.

Published:

Immunotherapy for Hodgkin Lymphoma

Are there Hodgkin lymphoma treatments on the horizon that can use a patient’s immune system against cancer? Watch as experts share research updates on treatments in development.

Published:

Epidemiological Research: What Causes Are Associated With Developing Hodgkin Lymphoma?

What factors increase a person’s risk of cancer? Watch now to hear experts Dr. Joshua Brody and Dr. Andrew Evens discuss causes linked with the development of Hodgkin lymphoma.

Published:

Understanding Treatment Options: What Is the Course of Care for Hodgkin Lymphoma?

How are novel agents being used in Hodgkin lymphoma care? Tune in to hear experts Dr. Andrew Evens and Dr. Joshua Brody discuss the use of targeted treatments and new frontline therapies.

Published:

Showing 9 of 15 programs

MPNs

ASH 2018 Coverage: A Scientist Shares Insight on Drug Development

As part of our coverage of the 2018 American Society of Hematology (ASH) Annual Meeting, Dr. Phillip Liu joined Patient Power to discuss the discovery of ruxolitinib (Jakafi).

Published:

MPN Headlines From ASH 2018 With Dr. Casey O’Connell

As part of our coverage of the 2018 American Society of Hematology (ASH) Annual Meeting, Dr. Casey L. O’Connell joined Patient Power to comment on the latest headlines in myeloproliferative neoplasms (MPNs).

Published:

Updates From ASH 2018: The Latest on Interferon Therapy in MPNs

MPN experts, Dr. Srdan Verstovsek and Dr. Abdulraheem Yacoub provide an update from ASH 2018, including the latest in interferon research for the treatment of polycythemia vera (PV).

Published:

MPN News From ASH 2018: Perspectives From Leading Experts

Tune in for ASH 2018 updates with MPN experts Dr. Srdan Verstovsek, Dr. Abdulraheem Yacoub and Lindsey Lyle as they discuss the latest news and developments related to MPN research and treatment.

Published:

ASH 2018 Daily Wrap: MPN News

On location in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of experts to discuss research developments announced at ASH 2018. Watch day one of Patient Power’s daily wrap to hear the latest blood cancer-related treatment news.

Published:

Myeloma

From Holistic Health Guru to Patient Advocate: The Importance of Respecting Evidence-Based Medicine

Myeloma patient and author Cherie Rineker shares how her perspective shifted from holistic care to becoming a myeloma treatment research advocate. Watch to learn why.

Published:

Myeloma News From ASH 2018: Patient Advocate Perspective

As part of our coverage of the 2018 American Society of Hematology (ASH) annual meeting, myeloma survivor and patient advocate Cindy Chmielewski shares her perspective on the latest news in multiple myeloma.

Published:

Myeloma News From ASH 2018: Encouraging Clinical Trial Updates From Dr. Ajai Chari

Patient Power founder Andrew Schorr is joined by leading myeloma expert Dr. Ajai Chari at the 2018 American Society of Hematology (ASH) annual meeting to discuss where there is an unmet need in myeloma care and share exciting clinical trial data with novel agents.

Published:

Myeloma News From ASH 2018: Groundbreaking Data for the Future of Myeloma

What's the recent groundbreaking data for the future of myeloma treatment? Watch as myeloma expert Dr. Fatih Davies shares research breakthroughs from ASH 2018.

Published:

Myeloma Expert Shares Highlights From ASH 2018

Patient Power founder Andrew Schorr is joined by multiple myeloma specialist Dr. James Berenson to discuss exciting research developments announced at the 2018 American Society of Hematology (ASH) annual meeting in an ever-changing treatment paradigm. Tune in to hear the latest news.

Published:

News From ASH 2018: A Multitude of Options in Myeloma

Dr. Robert Orlowski from The University of Texas MD Anderson Cancer Center weighs in on the flurry of myeloma news out of the ASH 2018 meeting.

Published:

Myeloma Patient Perspective: "MRD Testing Gave Me Peace of Mind"

Cherie Rineker, a myeloma patient, author and blogger shares her experience after having MRD testing.

Published:

Myeloma News From ASH 2018: CAR-T Therapy, Antibody Drug Conjugates, Maintenance Strategies

On-site in San Diego, CA, Patient Power founder Esther Schorr is joined by leading myeloma expert Dr. Amrita Krishnan to discuss highlights from the 2018 American Society of Hematology (ASH) annual meeting. Dr. Krishnan explains what exciting research advances were made and the “top three” in treatment development for myeloma patients.

Published:

ASH 2018 Daily Wrap: Myeloma News

In day two of Patient Power’s daily wrap-up from the 2018 American Society of Hematology (ASH) meeting in San Diego, Patient Power founders Andrew and Esther Schorr are joined by a panel of leading experts to discuss impressive treatment advances and important headlines in clinical research. Watch now to find out the latest news in cancer care.

Published:

Non-Hodgkin Lymphoma

Follicular Lymphoma Updates From ASH 2018

Dr. Neel Gupta speaks with Andrew Schorr about new and improving therapies for follicular lymphoma from ASH 2018.

Published:

Peripheral T-Cell Lymphoma Updates From ASH 2018 With Dr. Gupta

Lee Swanson is joined by Dr. Neel K. Gupta of Stanford University School of Medicine. They discuss changes since last year’s ASH meeting.

Published:

Updates From ASH 2018 Peripheral T-Cell Lymphoma With Dr. Horwitz

Dr. Steven Horwitz joins Lee Swanson to discuss new approvals and advancements made in peripheral T-cell lymphoma at ASH 2018. Dr. Steven Horwitz has been instrumental in these studies leading to approval for new treatments.

Published:

Advertisement
Unisciti alla nostra comunità Registrati per eventi Leggi il nostro ultimo blog
Advertisement

Page last updated on August 27, 2019